Owlet (OWLT) Gains from Investment Securities (2020 - 2021)

Owlet's (OWLT) quarterly Gains from Investment Securities came in at $970000.0 in Q2 2021, down 78.95% on a QoQ basis from $4.6 million in Q1 2021.

Owlet (OWLT) Gains from Investment Securities (2020 - 2021) Analysis & Trends

Owlet (OWLT) has 2 years of Gains from Investment Securities data on file, last reported at $970000.0 in Q2 2021.

On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to $970000.0 in Q2 2021; TTM through Mar 2022 was $970000.0, a N/A change from a year earlier, with the FY2021 full-year figure at $5.6 million, up 185.76% from the prior year.
Gains from Investment Securities for Q2 2021 stood at $970000.0, down from $4.6 million in the prior quarter.
Over the last five years, Gains from Investment Securities for OWLT reached as high as $7.2 million in Q4 2020 and fell as low as $1000.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn
10	Owlet	143.93 Mn	102.92 Mn	12.24 Mn

Download Data